Report Feature
The future of the global large molecule bioanalytical testing service market looks promising with opportunities in the oncology, infectious diseases, cardiology, and neurology therapeutic areas. The global large molecule bioanalytical testing service market is expected to grow with a CAGR of 8%-10% from 2020 to 2025. The major drivers for this market are increasing research and development expenditure in pharmaceutical and biopharmaceutical companies and rising share of large molecules in biopharmaceutical.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global large molecule bioanalytical testing service market report, please download the report brochure.
The study includes trends and forecast for the global large molecule bioanalytical testing service market by test type, type, phase, therapeutic area, end user, and region as follows:
By Test Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- ADME (Absorption, Distribution, Metabolism and Excretion)
- PK (Pyruvate Kinase)
- PD (Partial Discharge)
- Bioavailability
- Bioequivalence
- Other Test
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmacokinetics
- Anti Drug Antibody (ADA)
- Others
By Phase [Value ($ Million) shipment analysis for 2014 – 2025]:
- Preclinical
- With Antibody
- Without Antibody
- Clinical
By Therapeutic Area [Value ($ Million) shipment analysis for 2014 – 2025]:
- Oncology
- Infectious Diseases
- Cardiology
- Neurology
- Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Small and Mid Size Enterprise (SMEs)
- Large Firms
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the large molecule bioanalytical testing service companies profiled in this report include Covance, IQVIA, Syneos Health, SGS, Toxikon, Intertek Group, Pace Analytical Services, Charles River Laboratory, ICON, and PPD.
Lucintel forecasts that anti drug antibody (ADA) will remain the largest segment over the forecast period due to increasing prevalence of chronic diseases as ADA assays support the development of large molecule drugs by detecting anti drug antibodies.
Within this market, small and medium enterprise will remain the largest segment by end user over the forecast period due to increasing investment in the biopharmaceutical industry to enhance productivity and efficiency which has driven the bio-manufacturers to increase their focus on outsourcing activities.
North America will remain the largest region over the forecast period due to presence of highly reliable, complex, and high-end pharmaceutical companies and rapid technological advancements in the region.
|
Features of the Global Large Molecule Bioanalytical Testing Service Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global large molecule bioanalytical testing service market by test type (ADME, PK, PD, bioavailability, bioequivalence, and other test), type (pharmacokinetics, ADA, and others), phase (preclinical, with antibody, without antibody, and clinical), therapeutic area (oncology, infectious diseases, cardiology, neurology, and others), end user (SMEs and large firms), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global large molecule bioanalytical testing service market? Q.5 What are the business risks and threats to the global large molecule bioanalytical testing service market? Q.6 What are the emerging trends in this large molecule bioanalytical testing service market and the reasons behind them? Q.7 What are some changing demands of customers in this large molecule bioanalytical testing service market? Q.8 What are the new developments in this large molecule bioanalytical testing service market? Which companies are leading these developments? Q.9 Who are the major players in this large molecule bioanalytical testing service market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this large molecule bioanalytical testing service market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global large molecule bioanalytical testing service market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Test Type (ADME, PK, PD, Bioavailability, Bioequivalence, and Other Test), Type (Pharmacokinetics, ADA, and Others), Phase (Preclinical, With Antibody, Without Antibody, And Clinical), Therapeutic Area (Oncology, Infectious Diseases, Cardiology, Neurology, and Others), and End User (SMEs and Large Firms) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (Norway, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Large Molecule Bioanalytical Testing Service Market
4.1 Global Large Molecule Bioanalytical Testing Service Market by Region
4.2.1 Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.2.2 Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.2.3 Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.2.4 Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.2.5 Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.2.6 The United States Large Molecule Bioanalytical Testing Service Market
4.2.7 The Canadian Large Molecule Bioanalytical Testing Service Market
4.2.8 The Mexican Large Molecule Bioanalytical Testing Service Market
4.3.1 Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.3.2 Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.3.3 Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.3.4 Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.3.5 Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.3.6 The Large Molecule Bioanalytical Testing Service Market of United Kingdom
4.3.7 The German Large Molecule Bioanalytical Testing Service Market
4.3.8 The French Large Molecule Bioanalytical Testing Service Market
4.4.1 Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.4.2 Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.4.3 Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.4.4 Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.4.5 Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.4.6 The Chinese Large Molecule Bioanalytical Testing Service Market
4.4.7 The Indian Large Molecule Bioanalytical Testing Service Market
4.4.8 The Japanese Large Molecule Bioanalytical Testing Service Market
4.5.1 Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.5.2 Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.5.3 Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.5.4 Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.5.5 Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.5.6 Brazilian Large Molecule Bioanalytical Testing Service Market
7.1.1 Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Test Type
7.1.2 Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Type
7.1.3 Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Phase
7.1.4 Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Therapeutic Area
7.1.5 Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by End User
7.1.6 Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
